Gemcitabine: cutaneous, hepatic and vascular disorders
Prescrire International 18(101): 122
2009
ISSN/ISBN: 1167-7422 PMID: 19637433 Document Number: 12753
In addition to the adverse effects shared by all cytotoxic drugs, gemcitabine carries a risk of Lyell syndrome and other related cutaneous disorders, various types of liver damage (sometimes with positive rechallenge), and arterial thrombosis sometimes associated with necrosis.
Document emailed within 1 workday
Related Documents
Buletsa, B.A.; Durach, L.N.; Romaniuta, L.N. 1977: Diagnostic value of cutaneous vascular reactions in disorders of cerebral blood circulation Vrachebnoe Delo 5: 82-84Burstin, R.; Colbert, N.; de Montgolfier, S.; Helenon, C.; Bigot, J.M. 1985: Hepatic chemotherapy by hepatic arterial catheterization with an implantable system allowing permanent vascular access Annales de Gastroenterologie et d'Hepatologie 21(2): 103-108
Maeba, T.; Okano, K.; Mori, S.; Karasawa, Y.; Goda, F.; Wakabayashi, H.; Usuki, H.; Maeta, H. 2001: Retrohepatic vena cava replacement of hepatic malignancies without using total hepatic vascular exclusion or extracorporeal bypass Hepato-Gastroenterology 48(41): 1455-1460
Li, M-Hao.; Yan, L-Nan.; Wang, S-Ren. 2007: Autologous transfusion with modified total hepatic vascular exclusion for extracapsular resection of giant hepatic cavernous hemangioma Hepatobiliary and Pancreatic Diseases International: Hbpd Int 6(1): 43-48
Niki, T.; Yamamoto, Y.; Tsuda, M.; Horita, K.; Hirohata, S.; Nishisaki, H. 2009: Retrospective analysis of uracil/tegafur, cyclophosphamide and gemcitabine compared with gemcitabine monotherapy in unresectable pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(2): 273-278
Hoshino, H.; Takeda, Y.; Nagano, H.; Nakamori, S.; Kobayashi, S.; Eguchi, H.; Marubashi, S.; Tanemura, M.; Kitagawa, T.; Umeshita, K.; Monden, M.; Doki, Y.; Mori, M. 2009: A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2419-2421
Inal, A.; Kos, F.T.; Algin, E.; Yildiz, R.; Berk, V.; Tugba Unek, I.; Colak, D.; Colak, D.; Kucukoner, M.; Tamer Elkiran, E.; Helvaci, K.; Geredeli, C.; Dane, F.; Balakan, O.; Ali Kaplan, M.; Gok Durnali, A.; Harputoglu, H.; Goksel, G.; Ozdemir, N.; Buyukberber, S.; Gumus, M.; Ozkan, M.; Benekli, M.; Isikdogan, A. 2012: Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(1): 102-105
Yang, Y.; Zhao, L.-H.; Fu, S.-Y.; Lau, W.Y.; Lai, E.C.H.; Gu, F.-M.; Wang, Z.-G.; Zhou, W.-P. 2014: Selective hepatic vascular exclusion versus pringle maneuver in partial hepatectomy for liver hemangioma compressing or involving the major hepatic veins American Surgeon 80(3): 236-240
Biedermann, H. 1989: Results of micro(vascular) surgical interventions in vascular-induced disorders of erection Wiener Klinische Wochenschrift 101(21): 723-728
Mirtovskaia, V.N.; Loshkareva, N.N. 1991: Autonomic disorders in patients with initial signs of cerebro- vascular disorders in hypertension and arteriosclerosis and their non-pharmacological correction Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(5): 16-19
Essa, M.H.; Mangoud, A.M.; Morsy, T.A.; Aly, M.A.; Salama, M.M. 1989: Vascular changes in cutaneous leishmaniasis Journal of the Egyptian Society of Parasitology 19(2): 683-687
Piérard, G.E.; Piérard-Franchimont, C.; Arrese-Estrada, J.; Boniver, J.; Carlier, P.; de la Brassinne, M.; Delvoye, P.; Fazaa, B.; Gharbi, R.; Hermanns, J.F. 1988: Hamartomas and cutaneous vascular neoplasms Revue Medicale de Liege 43(21): 685-697
Péquignot, R.; Thévenot, T.; Permal, S.; Tulliez, M.; Legman, P.; Dhote, R.; Christoforov, B. 1999: Hepatic leiomyosarcoma revealed by cutaneous metastasis Gastroenterologie Clinique et Biologique 23(8-9): 991-992
Zaretskiĭ, M.M.; Vakhtina, T.I. 1980: Case of the cutaneous-hepatic form of porphyria Terapevticheskii Arkhiv 52(9): 116-117
1991: Laser treatment of cutaneous vascular lesions Medical Letter on Drugs and Therapeutics 33(856): 104-106
Pulitzer, D.R.; Martin, P.C.; Collins, P.C.; Reitmeyer, W.J. 1990: Cutaneous vascular calcification with ulceration in hyperparathyroidism Archives of Pathology and Laboratory Medicine 114(5): 482-484
Cohen, P.R.; Grossman, M.E.; Hebert, A.A.; Tunnessen, W.W. 1992: Picture of the month. Cutaneous vascular lesions American Journal of Diseases of Children 146(8): 955-956
Guérin, C.; Casez, J.P.; Vital-Durand, D.; Levrat, R. 1984: Allergy to paracetamol. a case of hepatic and cutaneous involvement Therapie 39(1): 47-49
Sunagozaka, H.; Yamashita, T.; Kagaya, T.; Kato, Y.; Kaneko, S. 2006: A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 829-832
Gagov, S.; Petrov, L.; Popova, A. 1976: On the neurogenic vasoconstriction of the resistive vessels in cutaneous vascular bed--rabbit ear Acta Physiologica et Pharmacologica Bulgarica 2(1): 39-45